Peapod Lane Capital LLC An2 Therapeutics, Inc. Transaction History
Peapod Lane Capital LLC
- $99.9 Billion
- Q2 2025
A detailed history of Peapod Lane Capital LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 582,770 shares of ANTX stock, worth $617,736. This represents 0.62% of its overall portfolio holdings.
Number of Shares
582,770
Previous 580,853
0.33%
Holding current value
$617,736
Previous $790 Million
21.8%
% of portfolio
0.62%
Previous 0.89%
Shares
3 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
7.58MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.43MShares$1.51 Million0.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.1 Million0.0% of portfolio
-
Stonepine Capital Management, LLC Bend, OR544KShares$577,1630.57% of portfolio
-
Landscape Capital Management, L.L.C.495KShares$525,1190.05% of portfolio
-
Bank Of Nova Scotia459KShares$486,7450.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $20.6M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...